Are you curious about which tumor cells to include when calculating TPS for NSCLC? Join Dr. Phillipe Taniere as he elucidates the process and walks you through a case study example. Gain first-hand knowledge and sharpen your skills by watching the full video here: https://bit.ly/3PAoOOH #PDL1 #TPS #NSCLC D0110826_1.00
Agilent Dako Pathology Solutions
Biotechnology Research
Santa Clara, California 5,242 followers
About us
We provide trusted answers, together with our customers, through our integrated pathology solutions. Our portfolio includes a full range of world-class products, service and support that meet the individual needs of your lab and enables efficient, cost-effective and accurate diagnosis for cancer patients.
- Website
-
http://www.agilent.com
External link for Agilent Dako Pathology Solutions
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Santa Clara, California
- Founded
- 1999
- Specialties
- Pathology, IHC, H&E, Diagnostics, Cancer Diagnostics, and Special Stains
Updates
-
Join #Agilent and special guest presenter Dr. Emina Torlakovic for the April A la Carte Webinar. Dr. Torlakovic will explore the clinical utility of different tools for the assessment of IHC LoD (limit of detection), why measuring LoD is clinically relevant, and where it fits in the workflow of clinical IHC laboratories. 🔬 Don't miss this opportunity to earn CEU credit. 💻 Can’t attend? The webinar will be available on-demand until April 26. ✅ https://bit.ly/49Z3kmY
-
-
Include the new p16 antibody for Agilent Dako Omnis in your menu for #cervical #cancer classification. Based on the trusted p16 clone JC8, this antibody is provided in FLEX ready-to-use format for Dako Omnis and is validated for use in classification of cervical nondysplastic, dysplastic, and neoplastic lesions. Visit the product page to see IHC stains and learn more: https://bit.ly/3VFGQ65 D0112101
-
-
Dr. David Hardisson guides us through a real case study on PD-L1 assessment in TNBC. Gain first-hand insights into making accurate assessments from the expert himself. If you want to deepen your understanding, watch the full video for a wealth of knowledge from Dr. Hardisson: https://bit.ly/3IK0BSe #pathology #TNBC #PDL1 #CPS D0110824_1.00
-
Want higher #immunohistochemistry throughput? See how four labs advanced their #pathology workflow with a holistic approach to tissue staining using Dako Omnis. Watch the full video here: https://bit.ly/3ITrUcL
-
Join #Agilent as we dive deep into the most pressing themes in pathology at #USCAP2024. Don’t miss our symposia on digital pathology solutions and PD-L1 CPS scoring. Stop by booth 205 for live digital pathology demos or test your scoring knowledge at our CPS learning stations. Discover how Magnis and TapeStation fit into your lab of the future. https://bit.ly/4cht3bO
-
-
PD-L1 status directly impacts a patient’s potential treatment. #Agilent and Dr. Alexandros Polydorides will present a training session to increase your confidence in PD-L1 CPS scoring. 💪 Don’t miss this opportunity while attending #USCAP2024. Click here for more information: https://bit.ly/49PDVMd
-
-
Did you know? Agilent Technologies provides more than just #antibodies - we also offer a broad #pathology solutions portfolio that includes instruments, reagents, software, digital pathology offerings, and service and support. Explore this interactive experience to see how Agilent pathology solutions support your lab's entire staining process. https://bit.ly/3TtRdsi D0110797_1.00 THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC
-
To what lengths should we go to ensure consistency in immunohistochemistry (IHC) testing across laboratories? Find out with #Agilent and special guest presenter Dr. Steven Bogen in the March A la Carte webinar. 🔬 Don't miss this opportunity to earn CEU credit. 💻 Can’t attend? The webinar will be available on-demand until March 29. ✅ Register NOW: https://bit.ly/3v18tvk PR7001-2191, D0111920_1.00
-
-
Digital pathology is increasing laboratory efficiency, clinical utility and quality control which results in reduction of time to diagnosis and improvement of patient outcomes. #Agilent is bringing together key opinion leaders in this can’t-miss symposium at #USCAP2024. Click here for more information: 👉 https://bit.ly/3vk7LcJ
-